Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2023-12-29 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
中国银河证券股份有限公司关于天津瑞普生物技术股份有限公司2023年持续督导的培训报告
Audit Report / Information Classification · 85% confidence The document is titled as a '2023 Year Continuous Supervision Training Report' by China Galaxy Securities Co., Ltd. regarding Tianjin Ruipu Biotechnology Co., Ltd. It describes a training session conducted on December 21, 2023, for the company's directors, supervisors, senior management, and controlling shareholders. The content focuses on regulatory compliance, governance, disclosure, and operational norms as per Shenzhen Stock Exchange guidelines. The document is relatively short (1108 characters) and is a report on a training event rather than a financial report or regulatory filing. It does not contain financial statements, audit results, or voting results. It is not an announcement of a report but a standalone report on training activities related to regulatory supervision. Therefore, it fits best under Audit Report / Information (AR) as it relates to regulatory compliance and supervision training, which is part of internal control and audit-related activities. FY 2023
2023-12-29 Chinese
关于出售资产的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of an asset sale by Tianjin Ruipu Biotechnology Co., Ltd. It details the completion of asset transfer procedures and the impact of the transaction on the company. The text includes no financial statements or detailed financial analysis, but rather a corporate update on a specific transaction. It is not a full financial report, audit report, or earnings release. It is also not a regulatory certification or voting result. The document is a corporate announcement about a capital asset transaction progress, which fits best under Capital/Financing Update (CAP). The document length is short and focused on the transaction progress, not a report publication or regulatory filing. Therefore, the classification is CAP with high confidence.
2023-12-15 Chinese
董事会薪酬与考核委员会工作细则（2023年12月）
Governance Information Classification · 100% confidence The document is titled as the "Board of Directors Remuneration and Assessment Committee Work Rules" of Tianjin Ruipu Biotechnology Co., Ltd. It details the establishment, composition, responsibilities, decision-making procedures, and rules of the Remuneration and Assessment Committee of the Board of Directors. The content focuses on governance practices related to board and senior management remuneration and assessment policies, referencing relevant laws and company bylaws. There is no financial data, earnings information, or report publication announcement. The document is a governance-related internal rules report about board committee structure and functions, which fits the Governance Information (CGR) category.
2023-12-12 Chinese
独立董事专门会议工作细则（2023年12月）
Governance Information Classification · 95% confidence The document is titled as '独立董事专门会议工作细则' which translates to 'Rules of Procedure for Independent Directors' Special Meetings' of Tianjin Reap Biotechnology Co., Ltd. It details the rules, procedures, and responsibilities related to independent directors' meetings, including meeting convening, voting, and record-keeping. There is no financial data, no mention of financial results, no shareholder voting results, no executive changes, no legal proceedings, no capital changes, and no report publication announcements. The content is focused on governance practices and internal rules related to independent directors. Therefore, the document fits best under Governance Information (CGR). The document length is 2479 characters, which is relatively short but contains substantive governance content, not just an announcement or notice. Hence, the classification is CGR with high confidence.
2023-12-12 Chinese
关于修改公司内部控制相关制度的公告
Governance Information Classification · 95% confidence The document is an announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding modifications to the company's internal control related systems. It references the board of directors' meeting and changes to governance-related rules such as the independent director system and board committees' working rules. There is no financial data, no mention of annual or quarterly reports, earnings, or audit results. The document focuses on governance system changes and internal control policies, which aligns with governance information filings. The document length is short and it is not a report itself but an announcement of changes to governance practices. Therefore, the most appropriate classification is Governance Information (CGR).
2023-12-12 Chinese
第五届董事会第十一次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board meeting of Tianjin Ruipu Biotechnology Co., Ltd. It details the convening of the board meeting, the approval of amendments to the company's articles of association and internal control systems, and voting results. It references compliance with company law and stock exchange rules. The document is not a full report but a formal announcement of board decisions and governance changes. It does not contain financial statements or detailed management discussion but focuses on board and governance matters. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear content and context.
2023-12-12 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.